ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First patient dosed for Phase I/II trial of avapritinib in advanced GIST
August 26, 2019CStone announces on a registrational bridging study in China which includes a Phase I dose-escalation study and Phase II dose-expansion study to evaluate safety, pharmacokinetics and efficacy of avapritinib in patients with metastatic gastrointestinal str -
CStone announces first patient dosed in China with avapritinib for advanced GIST
July 10, 2019Global Phase III clinical trial to evaluate the safety and efficacy of avapritinib as a 3rd or 4th line treatment for patients with gastrointestinal stromal tumours (GIST), in comparison with regorafenib
Pharma Sources Insight January 2025
